Lung bronchioloalveolar carcinoma

Product name Lung bronchioloalveolar carcinoma
Cat. No. 2882503A
No. of samples 1
Description lung, bronchioloalveolar carcinoma
Age/Sex : 67/M
Price 197 EUR
260 USD
170 GBP

Lung bronchioloalveolar carcinoma

Product Related Literature

Bronchioles cancer shows the growth pattern noninvasive particular first results of alveoli and bronchi fine distal, is a term used to describe specific embodiments of the lungs. The BAC, that is a type of a non-small cell lung cancer, lung cancer, heterogeneous family extremely malignant neoplasm, histological of more than 50 recognized by the review of the typing system 2004 is a classification that currently, the most widely used of lung cancer scheme is a subspecies. It is possible to include the response to therapy, genetic very different, with the clinical characteristics and biological correct classification of lung cancer cases, these embodiments to undergo optimum control in lung cancer patients would be required to ensure.

Adenocarcinoma, papillary adenocarcinoma, and in strong adenocarcinoma with mucin production, is one of the histological subtype of four specific lung adenocarcinoma -2004 tapir. However, it contains a (or more) about 80% of adenocarcinomas two subtypes of these four is found. Multi-tumor that is classified as a fifth, “subtype”, they are referred to as adenocarcinoma in different subtypes. There are classification system other lung adenocarcinoma comprising other, have been proposed and Bak. In Japan, Noguchi classification system for small adenocarcinoma has received considerable attention in particular, is widely used, it is not a recognized by the WHO system. As with other forms of lung cancer, BAC is, has a pathological features and unique clinical outcomes, I will respond to different treatments.

Diagnostic criteria of Bach, have changed since 1999. According to the new definition, BAC, without tumor the main organization, to start the destruction and invasion of lymphatic and blood vessels, has been defined as the growth of the fashion (ie, peeling the cover) to scaly by the existing structure of the respiratory tract You. Because it must exclude the invasion, BAC can be diagnosed after the study of tumors did not use the cytological sample or biopsy profiling and complete only. In addition, BAC is considered after and progression mutations to be pre-invasive malignancies that generates invasive cancer in the end. Therefore, I have considered a form of carcinoma in situ.

Diagnostic criteria of the BAC, has changed since 1999. According to the new definition, BAC will be considered for invasive tumor pathology, but it does not have the form of carcinoma in situ and (CIS). As with other forms of CIS, BAC, and can indicate malignant behavior often fatal, to develop, to become aggressive indeed. Usually a need to control it, as with other forms of non-small cell lung cancer, or lung lobectomy is a common or recurrent major surgery. Therefore, the tumor is invasive tumor, I was classified in other malignancies. Under the criteria of a new and more rigorous for the classification of lung WHO, much more frequently, BAC is diagnosed than in the past and present. A recent study shows that it is comprised between 3% BAC, and 5% of all lung cancers in the United States

The frequency of bronchial alveolar cell carcinoma, can be changed by 24% from four of all patients with lung cancer have been reported. Analysis of (SEER) registry final results of others and lead surveillance and epidemiology. However, it was shown that the incidence of SAC increased to 20 years, and continues to be less than 4% of NSCLC in each time interval. This difference in frequency is given to the complex histopathology of cancer. The increase in frequency shown in various studies pure BAC is like, but is rare, in 1999, it may be due to a clear histological classification the person who came up with the rankings in 2004 then. It is equal proportions, another feature of the BAC is to give effect to men and women, but also in several recent studies, it indicates the incidence slightly higher among women.

Believed to result from respiratory agents distal end and transformed cells in the airways, mucus BAC indicates differentiation characteristics of type II lung cells or Clara cells often. On the other hand, the BAC mucus, transformed cells derived from in bronchial glands probably far. Cystic adenomatous malformations (CAM), I have been identified as a precursor lesion in the development of mucus BAC recently, cases of these types are rare. It is not possible to develop a BAC rhabdoid form for the development of high-density rare perinuclear inclusions.